Seeking Alpha

gostockyourself » Comments |

Sort by:
Latest | Highest rated
  • Newegg Files for IPO: What's Behind Their $2 Billion in Sales? [View article]
    agree'd, old article, but newegg is superior compared to amazon. im surprised to see their numbers are so little, and profit margin so low! the margin concerns me as a potential investor. but as a fan i'd buy a good chunk of them to offset my purchases through them annually. they do provide an easy filter system, best prices, and terrific customer service.
    Dec 01 08:34 am |Rating: 0 0 |Link to Comment
  • Holiday Cheer: Cel-Sci Should Have Good News [View article]
    VFC, please comment on ABIO

    this is a multi bagger for sure, great treatment for heart failure, was originally declined due to bad trial design (goofed up internally).

    replaced management.

    now their product has been Fast Tracked. that speaks volume, as their trial DID show awesome results, but it was the design failure that left out key statistics.

    although its not going to get approval for at least another year, the potential is huge.
    Nov 25 09:24 am |Rating: +1 -1 |Link to Comment
  • CytRx Corporation: Key Developments Ahead [View article]
    "someone knows something one investor said"

    wow ME stooped to an all time low, sounds like you do your DD on message boards haha.
    Nov 24 12:53 pm |Rating: +1 0 |Link to Comment
  • Spectrum Pharma: Zevalin Has Blockbuster Potential [View article]
    keep pumping amigo...you might as well write an article on shorting this.
    Oct 26 07:59 am |Rating: 0 -1 |Link to Comment
  • Oncothyreon and OncoGenex: Room to Rise [View article]
    checkout KVA generic pharma mfg, huge rise lately with news on the horizon, probably a approval to continue mfg, do your own dd but i see a 5 bagger in short order.

    GLTA. i try and stay away from these R&D based investments. generics is the way to go (i.e. CPD)
    Oct 19 07:53 am |Rating: +1 0 |Link to Comment
  • BioMed News Bytes: Dendreon, Chelsea, Cytori, Cephalon, OraSure, Genzyme, Lixte [View article]
    all these biotechs are boring me now, was exciting 3-6 months ago.
    Sep 25 07:11 am |Rating: 0 0 |Link to Comment
  • Cytori Therapeutics' Cardiac Celution: Encouraging Interim Data [View article]
    You spelled wound wrong first paragraph. Otherwise thanks for the in depth read, i look forward to the emerging leaders in step cell therapy. it will put current biotech science into old school industry.
    Sep 24 07:06 am |Rating: 0 -1 |Link to Comment
  • Citigroup Advertises 'FDIC-Insured' Forex Daytrading Accounts [View article]
    this made my day. great find!

    -god bless america lol
    Aug 19 14:21 pm |Rating: +1 -1 |Link to Comment
  • CryoCell Has a Future to Bank On [View article]
    been watching them since .50's, as you said, very thinly traded.
    250%+/ytd though.
    Aug 13 07:59 am |Rating: 0 0 |Link to Comment
  • BioDelivery Science: A Buy I Couldn't Refuse [View article]
    whats your 3mo/60mo/1yr target price?

    (sites super slow or i'd be more then willing to look back at your previous articles).
    Aug 13 07:53 am |Rating: 0 0 |Link to Comment
  • Spectrum Pharmaceuticals: Rumors of Buyout Talks Persist [View article]
    im also interested on your take with undervaluded pharma mfg's....

    opinion on CPD and recent price movement?
    Aug 11 10:43 am |Rating: 0 0 |Link to Comment
  • FDA Calendar: 18 Hot Summer Trades [View article]
    great coverage, i own about 6 of those. next 30 days will be exciting.
    Jun 16 09:10 am |Rating: 0 0 |Link to Comment
  • 7 Small Cap Stock Briefs [View article]
    VFC your articles arent too shabby, you seem to do SOME biotech DD, really miss alot of good picks though :-(

    titan is going to be great, 2 or 3 bagger for sure within next couple months.

    checkout KV.A, and INSM this week!
    Jun 15 10:35 am |Rating: 0 0 |Link to Comment
  • Will Insmed's IPLEX Meet Expectations? [View article]
    yes IPLEX will meet and beat expectations.

    in fact there are several indications you failed to mention, you should do mor DD and write a follow up article within the week to really portray INSM value.
    May 18 08:49 am |Rating: +2 -1 |Link to Comment
  • Pending Clinical Trial Results: Ten Extreme Trades  [View article]
    INSM is the only one out of those that is a real winner:

    -cash flow neutral
    -zero debt
    -130m cash
    -phase IIb data to be released any day now
    --already has positive results from prior clinical trials
    ---life threatening disease ALS and MMD means p2b results will approve drug

    this is a real sleeper, dont miss out, less then 4 weeks.
    May 14 11:21 am |Rating: 0 0 |Link to Comment
Comments by Ticker
gostockyourself's
Comments Stats
16 comments
Rating: -26 (8 - 34 )